CPB
30
6
STI
14
-17
ISRG
74
-2
HPQ
63
6
XYL
49
4
CAH
48
-5
PGR
65
2
TGT
22
2
PSX
47
2
DD
63
3
GE
67
2
NVDA
56
-4
KLAC
47
4
MET
72
5
DE
63
3
CHRW
56
-3
CMG
72
5
EBAY
47
4
DNB
82
4
AIV
72
2
CPB
30
6
STI
14
-17
ISRG
74
-2
HPQ
63
6
XYL
49
4
CAH
48
-5
PGR
65
2
TGT
22
2
PSX
47
2
DD
63
3
GE
67
2
NVDA
56
-4
KLAC
47
4
MET
72
5
DE
63
3
CHRW
56
-3
CMG
72
5
EBAY
47
4
DNB
82
4
AIV
72
2
Financhill
Back

Globalstar 10K Form

Buy
59

GSAT
Globalstar

Last Price:
1.79
Seasonality Move:
46.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GSAT News And Ratings

See the #1 stock for the next 7 days that we like better than GSAT

GSAT Financial Statistics

Sales & Book Value

Annual Sales: $223.81M
Cash Flow: $5.48M
Price / Cash Flow: 0
Annual Sales: $0.21
Price / Book: 8.6

Profitability

EPS (TTM): -0.02480
Net Income (TTM): $-28.02M
Gross Margin: $154.34M
Return on Equity: -7.31%
Return on Assets: -3.05%

Globalstar Earnings Forecast

Key Globalstar Financial Ratios

  • The Gross Profit Margin over the past 21 years for GSAT is 68.96%.
  • The Selling, General & Administrative Expenses for GSAT have been equal to 29.47% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 407.60% of Operating Income.
  • The Net Earning history of GSAT is -11.04% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Globalstar Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Diversified Telecommunication Services
Sector: Communication Services
Current Symbol: GSAT
CUSIP: 378973
Website: globalstar.com

Debt

Debt-to-Equity Ratio: 1
Current Ratio: 1.09
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GSAT Technical Analysis vs Fundamental Analysis

Buy
59
Globalstar (GSAT) is a Buy

Is Globalstar a Buy or a Sell?

  • Globalstar stock is rated a Buy
    The current Globalstar [GSAT] share price is $1.79. The Score for GSAT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.